Skip Navigation LinksHome > January 2013 - Volume 21 - Issue 1 > Use of Ceftaroline in Complicated Methicillin-Resistant Stap...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3182602205
Case Reports

Use of Ceftaroline in Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia

Zainah, Hadeel MD; Vazquez, Jose A. MD

Collapse Box

Abstract

Abstract: Ceftaroline is a novel broad-spectrum cephalosporin approved in October 2010 by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by different organisms, including methicillin-resistant Staphylococcus aureus. We report 2 cases where ceftaroline was used effectively to treat complicated methicillin-resistant S aureus bacteremia.

© 2013 Lippincott Williams & Wilkins, Inc.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.